Skip to main content
. Author manuscript; available in PMC: 2023 Dec 8.
Published in final edited form as: Curr Diab Rep. 2022 Jul 11;22(9):461–470. doi: 10.1007/s11892-022-01485-w

Table 1.

Classification, clinical features, and etiology of the four major subtypes of lipodystrophy

Generalized Partial
Genetic Acquired Genetic Acquired
Subtype Congenital generalized lipodystrophy Acquired generalized lipodystrophy Familial partial lipodystrophy Acquired partial lipodystrophy
Genes for autosomal recessive subtypes AGPAT2, BSCL2, CAV1, CAVIN1 [1013] None CIDEC, LIPE, PCYT1A [1418] None
Genes for autosomal dominant subtypes None None LMNA, PPARG, AKT2, PLIN1, ADRA2A [1924] None
Pathogenesis Inability to store triglycerides in adipose tissue Autoimmune, panniculitis, idiopathic (perilipin 1 autoantibody) Various different mechanisms Autoimmune (Complement 3 nephritic factor autoantibody)
Lipodystrophy phenotype Near total absence of body fat since birth or soon after Gradual loss of subcutaneous fat from nearly entire body Absence of fat from the limbs Absence of fat from the upper body, including the face, neck, arms and chest
Metabolic complications + + + Mild or none
+

Present